首页 | 本学科首页   官方微博 | 高级检索  
     


Prospective evaluation of 68Ga‐DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers
Authors:Sophie Gabriel  Philippe Garrigue  Laetitia Dahan  Frédéric Castinetti  Frédéric Sebag  Karine Baumstark  Cendrine Archange  Abhishek Jha  Karel Pacak  Benjamin Guillet  David Taïeb
Affiliation:1. Department of Nuclear Medicine, La 2. Timone & North University Hospital, Aix‐Marseille University, Marseille, France;3. European Center for Research in Medical Imaging, Aix‐Marseille University, Marseille, France;4. Department of Radiopharmacy, La Timone & North University Hospital, Aix‐Marseille University, Marseille, France;5. Digestive Oncology Unit, La Timone University Hospital, Aix‐Marseille University, Marseille, France;6. Department of Endocrinology, Conception Hospital, Aix‐Marseille University, Marseille, France;7. Department of Endocrine Surgery, Conception Hospital, Aix‐Marseille University, Marseille, France;8. Department of Public Health, Aix‐Marseille University, Marseille, France;9. Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health, Bethesda, MD, USA;10. Inserm UMR1068 Marseille Cancerology Research Center, Institut Paoli‐Calmettes, Marseille, France
Abstract:
Keywords:biomarker  gallium radiopharmaceuticals  neuroendocrine tumour  positron emission tomography  somatostatin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号